Caricamento...
Retreatment with Pegloticase after a Gap in Therapy in Patients with Gout: A Report of Four Cases
INTRODUCTION: Pegloticase, a potent uricolytic biologic enzyme, has been shown to be an effective therapeutic option in patients with uncontrolled gout. However, there are limited data on clinical response after a gap in therapy and retreatment with pegloticase. CASE SERIES: This report describes fo...
Salvato in:
| Pubblicato in: | Rheumatol Ther |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Healthcare
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6251856/ https://ncbi.nlm.nih.gov/pubmed/29725991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-018-0111-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|